Sensorium Therapeutics learned that the Grady Trauma Project in Atlanta (Emory University) is one of the largest trauma studies ever conducted.

Public source

Publisher name

Public post

"Are there aspects of trauma that can be intergenerationally transmitted? Moms with a history of trauma—their kids had a higher startle response." Kerry Ressler's Grady…

Log in to read the full post

Company

Sensorium Therapeutics

Thriving by nature.

Industry
Biotechnology Research
Location
Boston, US
Company size
11–50 employees

About Sensorium Therapeutics

Sensorium Therapeutics is a clinical stage biotechnology company developing brain and mental health treatments that are derived from nature, mechanistically driven, clinically precise, and designed to help people thrive. Its proprietary SensAI™ platform integrates artificial intelligence, chemistry, and neuroscience to mine more than 50 million curated relationships across biology, pharmacology, clinical outcomes, and human experience to unlock broader and derisked starting points for CNS drug discovery. SensAI has produced three differentiated programs in under three years, led by SENS-01, a first-in-class treatment for anxiety. Visit sensorium.bio to learn more.

See more

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.